secwatch.observer — SEC 8-K summary
======================================

Issuer:     Decoy Therapeutics Inc. (DCOY)
CIK:        0001615219
Form:       8-K
Filed at:   2025-10-06T23:59:59+00:00
Accession:  0001615219-25-000142
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Salarius raises $6.2M; believes Nasdaq equity compliance regained ahead of Oct 20 deadline
--------------------------------------------------------------------------------

- Raised $2.4M from ATM sales (434,882 shares) and $3.8M from C/M Capital Master Fund purchase agreement.
- Believes stockholders' equity now exceeds $2.5M as of Oct 6, 2025; awaiting Nasdaq confirmation.
- Previously faced Nasdaq delisting risk if compliance not met by Oct 20, 2025.
- Q3 10-Q expected to reflect equity above $2.5M as of Sept 30, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1615219/000161521925000142/0001615219-25-000142-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1615219/000161521925000142/flks-20251006.htm
  HTML page:      https://secwatch.observer/filing/0001615219-25-000142

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer